scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.DIABET.2010.02.001 |
P698 | PubMed publication ID | 20447851 |
P2093 | author name string | M Buysschaert | |
V Preumont | |||
M-P Hermans | |||
S Brichard | |||
P433 | issue | 4 | |
P921 | main subject | preproinsulin | Q7240673 |
P304 | page(s) | 293-298 | |
P577 | publication date | 2010-05-05 | |
P1433 | published in | Diabetes and Metabolism | Q15758385 |
P1476 | title | Six-month exenatide improves HOMA hyperbolic product in type 2 diabetic patients mostly by enhancing beta-cell function rather than insulin sensitivity | |
P478 | volume | 36 |
Q26829445 | Assessment of pancreatic β-cell function: review of methods and clinical applications |
Q43769439 | Comparison of the effects on glycaemic control and β-cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel-group trial (the CONFIDENCE study). |
Q46869132 | Effects of exenatide and metformin in combination on some adipocytokine levels: a comparison with metformin monotherapy |
Q36877205 | Evolution of exenatide as a diabetes therapeutic |
Q52668530 | Exendin-4 modifies adipogenesis of human adipose-derived stromal cells isolated from omentum through multiple mechanisms. |
Q37900151 | From theory to clinical practice in the use of GLP-1 receptor agonists and DPP-4 inhibitors therapy |
Q34586302 | Intensive therapy in newly diagnosed type 2 diabetes: results of a 6-year randomized trial |
Q35493180 | Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes. |
Q51373270 | The metabolic syndrome influences the response to incretin-based therapies. |
Search more.